* Hims & Hers Health Inc reported quarterly adjusted earnings of 5 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of eleven analysts for the quarter was for earnings of one cent per share. Wall Street expected results to range from -4 cents to 3 cents per share.
* Revenue rose 45.8% to $278.17 million from a year ago; analysts expected $270.38 million.
* Hims & Hers Health Inc's reported EPS for the quarter was 5 cents.
* The company reported quarterly net income of $11.13 million.
* Hims & Hers Health Inc shares had fallen by 27.2% this quarter and gained 26.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 137.5% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Hims & Hers Health Inc is $16.00 This summary was machine generated from LSEG data May 6 at 10:05 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.01 0.05 Beat
Dec. 31 2023 -0.02 0.01 Beat
Sep. 30 2023 -0.03 -0.04 Missed
Jun. 30 2023 -0.05 -0.03 Beat
Comments